How do hospital procurement cycles affect purchasing decisions in the Neuroscience Market?

Most hospitals operate on 3–5 year capital-equipment replacement cycles, meaning MRI and EEG procurement tends to cluster around budget approval windows. Vendors offering lease-to-own or pay-per-scan options can bypass these cycles and accelerate adoption. Read More

What role do contract research organizations play in driving demand within the Neuroscience Market?

CROs manage an estimated 65% of Phase II–III CNS clinical trials, creating consistent demand for neuroimaging endpoints and EEG monitoring services. Their centralized purchasing amplifies per-site equipment utilization rates. Read More

How does intellectual-property strategy differ among Neuroscience Market competitors?

Large imaging OEMs rely on broad patent portfolios covering hardware and reconstruction algorithms, while neurotech startups pursue narrow but defensible claims around electrode materials and signal-processing methods. Cross-licensing agreements are increasingly common. Read More

What reimbursement changes could most accelerate Neuroscience Market growth in the next three years?

Expansion of CMS coverage for blood-based Alzheimer's biomarker panels and Medicare add-on payments for AI-assisted stroke triage would unlock significant volume. Both are under active CMS review as of 2025. Read More

How are academic medical centers influencing commercial dynamics in the Neuroscience Market?

AMCs serve as early adopters and reference sites for novel imaging and stimulation platforms, effectively validating technologies before community hospitals adopt them. Vendor partnerships with AMCs shorten regulatory review by generating real-world evidence. Read More

What cybersecurity risks are unique to connected neurostimulation devices in the Neuroscience Market?

Implantable DBS and BCI systems transmit sensitive neural data wirelessly, creating attack surfaces for unauthorized parameter changes. The FDA's 2024 draft guidance now mandates encryption and anomaly-detection firmware for all new submissions. Read More

How do reimbursement models in the Neuroscience Market differ between single-payer and multi-payer health systems?

Single-payer systems negotiate centralized pricing that lowers per-unit costs but extends procurement timelines. Multi-payer environments allow faster adoption but create coverage fragmentation that limits equitable patient access. Read More

What is the current size of the neuroscience market?

The neuroscience market reached USD 41.60 billion in 2025 and is projected to reach USD 77.73 billion by 2035. Read More

What is the CAGR of the neuroscience market?

The neuroscience market is projected to grow at a CAGR of 6.5% during the forecast period 2026–2035. Read More

Which region leads the neuroscience market?

North America holds the largest share at approximately 45%, while Asia-Pacific is the fastest-growing region at 7.5% CAGR. Read More

Neuro-science Market (2026 - 2035)

ID: MRFR/HC/21154-HCR

100 Pages

Satyendra Maurya

Last Updated: July 10, 2026

Neuroscience Market Research Report By Neuroscience Technique (Neuroimaging, Electrophysiology, Behavioral Neuroscience, Neurogenetics, Computational Neuroscience), By Application (Neurology, Psychiatry, Addiction Treatment, Drug Discovery, Neuromarketing), By End User (Hospitals & Clinics, Research Institutions, Pharmaceutical Companies, Biotechnology Companies, Educational Institutions), By Product (MRI Systems, CT Scanners, PET Scanners, EEG Systems, EMG Systems) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Industry Forecast to 2035.

Neuro-science Market

Market Size

Forecast Period2026-2035

CAGR (2026-2035)6.5%

2025 Market SizeUSD 41.60 Billion

2035 Market SizeUSD 77.73 Billion

Key Players

Siemens Healthineers

GE HealthCare

Philips Healthcare

Medtronic

Boston Scientific

Abbott Laboratories

Trends

Rising Global Neurological Disease Burden
Government Brain-Science Funding Programs
Ultra-High-Field MRI and Hybrid Imaging Adoption

Opportunities

Portable and Point-of-Care Neurodiagnostics
Precision Psychiatry and Digital Biomarkers
Emerging-Market Hospital Infrastructure Expansion

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Takeaways
3 Market Dynamics |
1. 3.1 Market Drivers Analysis | |
  1. 3.1.1 Rising Global Neurological Disease Burden | |
  2. 3.1.2 Government Brain-Science Funding Programs | |
  3. 3.1.3 Ultra-High-Field MRI and Hybrid Imaging Adoption | |
  4. 3.1.4 AI-Powered Neuro-Analytics Platforms | |
  5. 3.1.5 Non-Invasive Neurostimulation Regulatory Clearances | |
  6. 3.1.6 Brain-Computer Interface Commercialization | |
  7. 3.1.7 Aging Population Demographics |
2. 3.2 Market Restraints Analysis | |
  1. 3.2.1 High Upfront Capital Costs for Advanced Imaging | |
  2. 3.2.2 Ethical and Regulatory Uncertainty Around Invasive Neurotechnologies | |
  3. 3.2.3 Reimbursement Uncertainty for Novel Neurodiagnostic Procedures | |
  4. 3.2.4 Skilled Workforce Shortages in Neuroimaging and Neuro-Engineering | |
  5. 3.2.5 Data Privacy and Interoperability Challenges |
3. 3.3 Market Opportunity Analysis | |
  1. 3.3.1 Portable and Point-of-Care Neurodiagnostics | |
  2. 3.3.2 Precision Psychiatry and Digital Biomarkers | |
  3. 3.3.3 Emerging-Market Hospital Infrastructure Expansion | |
  4. 3.3.4 Data Monetization Through Federated Neuro-Data Platforms | |
  5. 3.3.5 Neurorehabilitation Robotics Integration |
4. 3.4 Industry Value Chain Analysis |
5. 3.5 Porter's Five Forces Analysis
4 Global Neuroscience Market Size & Forecast (2021–2035) |
1. 4.1 Historical Market Size (2021–2025) |
2. 4.2 Current & Forecast Market Size (2026–2035) |
3. 4.3 Market Size by Revenue (USD Billion) |
4. 4.4 Year-over-Year Growth Analysis
5 Segmentation Analysis |
1. 5.1 By Product | |
  1. 5.1.1 Instruments | |
  2. 5.1.2 Consumables | |
  3. 5.1.3 Software & Services |
2. 5.2 By Technology | |
  1. 5.2.1 Neuroimaging | |
  2. 5.2.2 Molecular & Cellular Assays | |
  3. 5.2.3 Neurostimulation & Others |
3. 5.3 By Application | |
  1. 5.3.1 Diagnostics | |
  2. 5.3.2 Research & Academic | |
  3. 5.3.3 Therapeutics Monitoring & Others |
4. 5.4 By End User | |
  1. 5.4.1 Hospitals & Clinics | |
  2. 5.4.2 Research Institutions | |
  3. 5.4.3 Diagnostic Laboratories | |
  4. 5.4.4 Pharmaceutical & Biotech Companies
6 Regional Analysis |
1. 6.1 North America | |
  1. 6.1.1 United States | |
  2. 6.1.2 Canada | |
  3. 6.1.3 Mexico |
2. 6.2 Europe | |
  1. 6.2.1 Germany | |
  2. 6.2.2 United Kingdom | |
  3. 6.2.3 France | |
  4. 6.2.4 Italy | |
  5. 6.2.5 Spain | |
  6. 6.2.6 Nordic Countries | |
  7. 6.2.7 Russia | |
  8. 6.2.8 Rest of Europe |
3. 6.3 Asia-Pacific | |
  1. 6.3.1 China | |
  2. 6.3.2 India | |
  3. 6.3.3 Japan | |
  4. 6.3.4 South Korea | |
  5. 6.3.5 ASEAN | |
  6. 6.3.6 Rest of Asia-Pacific |
4. 6.4 South America | |
  1. 6.4.1 Brazil | |
  2. 6.4.2 Argentina | |
  3. 6.4.3 Rest of South America |
5. 6.5 Middle East & Africa | |
  1. 6.5.1 Saudi Arabia | |
  2. 6.5.2 UAE | |
  3. 6.5.3 South Africa | |
  4. 6.5.4 Egypt | |
  5. 6.5.5 Rest of MEA
7 Competitive Landscape |
1. 7.1 Market Share Analysis (2026) |
2. 7.2 Competitive Benchmarking Matrix |
3. 7.3 Company Profiles | |
  1. 7.3.1 Siemens Healthineers | |
  2. 7.3.2 GE HealthCare | |
  3. 7.3.3 Philips Healthcare | |
  4. 7.3.4 Medtronic | |
  5. 7.3.5 Boston Scientific | |
  6. 7.3.6 Abbott Laboratories | |
  7. 7.3.7 Nihon Kohden | |
  8. 7.3.8 Compumedics | |
  9. 7.3.9 Elekta | |
  10. 7.3.10 Blackrock Neurotech
8 Future Outlook & Strategic Recommendations (2026–2035) |
1. 8.1 AI-Augmented Clinical Neuroscience |
2. 8.2 Platform Economics and Data-as-a-Service |
3. 8.3 Neurorehabilitation and Closed-Loop Therapeutics |
4. 8.4 ESG, Neuroethics, and Responsible Innovation
9 Recent Developments & News
10 Frequently Asked Questions (FAQs)
11 Report Scope & Methodology |
1. 11.1 Study Period & Base Year |
2. 11.2 Data Sources & Citations |
3. 11.3 Abbreviations
12 LIST OF TABLES |
TABLE 1 Global Neuroscience Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Neuroscience Market — Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Global Neuroscience Market — Driver Impact Analysis |
TABLE 4 Global Neuroscience Market — Restraints Impact Analysis |
TABLE 5 Global Neuroscience Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 6 Global Neuroscience Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 7 Global Neuroscience Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 8 Global Neuroscience Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 9 Global Neuroscience Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 10 North America Neuroscience Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Europe Neuroscience Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 12 Asia-Pacific Neuroscience Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 13 South America Neuroscience Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 14 Middle East & Africa Neuroscience Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 15 Competitive Benchmarking Matrix — Global Neuroscience Market, 2026 |
TABLE 16 Company Profiles — Key Players, Global Neuroscience Market |
TABLE 17 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 18 Report Scope & Methodology Summary |
TABLE 19 Detailed Sources and Citations |
TABLE 20 North America Neuroscience Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 21 North America Neuroscience Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 22 North America Neuroscience Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 23 North America Neuroscience Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 24 Europe Neuroscience Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 25 Europe Neuroscience Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 26 Europe Neuroscience Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 27 Europe Neuroscience Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 28 Asia-Pacific Neuroscience Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 29 Asia-Pacific Neuroscience Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 30 Asia-Pacific Neuroscience Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 31 Asia-Pacific Neuroscience Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 32 South America Neuroscience Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 33 South America Neuroscience Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 34 South America Neuroscience Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 35 South America Neuroscience Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 36 Middle East & Africa Neuroscience Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 37 Middle East & Africa Neuroscience Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 38 Middle East & Africa Neuroscience Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 39 Middle East & Africa Neuroscience Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 40 United States Neuroscience Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 41 United States Neuroscience Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 42 United States Neuroscience Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 43 United States Neuroscience Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 44 Canada Neuroscience Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 45 Canada Neuroscience Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 46 Canada Neuroscience Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 47 Canada Neuroscience Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 48 Mexico Neuroscience Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 49 Mexico Neuroscience Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 50 Mexico Neuroscience Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 51 Mexico Neuroscience Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 52 Germany Neuroscience Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 53 Germany Neuroscience Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 54 Germany Neuroscience Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 55 Germany Neuroscience Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 56 United Kingdom Neuroscience Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 57 United Kingdom Neuroscience Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 58 United Kingdom Neuroscience Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 59 United Kingdom Neuroscience Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 60 France Neuroscience Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 61 France Neuroscience Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 62 France Neuroscience Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 63 France Neuroscience Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 64 China Neuroscience Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 65 China Neuroscience Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 66 China Neuroscience Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 67 China Neuroscience Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 68 India Neuroscience Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 69 India Neuroscience Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 70 India Neuroscience Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 71 India Neuroscience Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 72 Japan Neuroscience Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 73 Japan Neuroscience Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 74 Japan Neuroscience Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 75 Japan Neuroscience Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 76 South Korea Neuroscience Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 77 South Korea Neuroscience Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 78 South Korea Neuroscience Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 79 South Korea Neuroscience Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 80 Brazil Neuroscience Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 81 Brazil Neuroscience Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 82 Brazil Neuroscience Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 83 Brazil Neuroscience Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 84 Saudi Arabia Neuroscience Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 85 Saudi Arabia Neuroscience Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 86 Saudi Arabia Neuroscience Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 87 Saudi Arabia Neuroscience Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 88 UAE Neuroscience Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 89 UAE Neuroscience Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 90 UAE Neuroscience Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 91 UAE Neuroscience Market Size, by End User, 2021–2035 (USD Billion)
13 LIST OF FIGURES |
FIGURE 1 Global Neuroscience Market Dynamics Overview |
FIGURE 2 Industry Value Chain Analysis — Neuroscience Market |
FIGURE 3 Porter's Five Forces Analysis — Neuroscience Market |
FIGURE 4 Global Neuroscience Market Size Trend & Forecast (USD Billion), 2021–2035 |
FIGURE 5 Global Neuroscience Market Share, by Product (%), 2025 |
FIGURE 6 Global Neuroscience Market Share, by Technology (%), 2025 |
FIGURE 7 Global Neuroscience Market Share, by Application (%), 2025 |
FIGURE 8 Global Neuroscience Market Share, by End User (%), 2025 |
FIGURE 9 Global Neuroscience Market Share, by Region (%), 2025 |
FIGURE 10 North America Neuroscience Market Share, by Country (%), 2025 |
FIGURE 11 Europe Neuroscience Market Share, by Country (%), 2025 |
FIGURE 12 Asia-Pacific Neuroscience Market Share, by Country (%), 2025 |
FIGURE 13 South America Neuroscience Market Share, by Country (%), 2025 |
FIGURE 14 Middle East & Africa Neuroscience Market Share, by Country (%), 2025 |
FIGURE 15 Competitive Landscape — Neuroscience Market Revenue Share (%), 2026 |
FIGURE 16 Company Positioning Matrix — Neuroscience Market, 2026

Certified Researchers

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
By Product	Instruments; Consumables; Software & Services	Instruments	Software & Services
By Technology	Neuroimaging; Molecular & Cellular Assays; Neurostimulation & Others	Neuroimaging	Neurostimulation & Others
By Application	Diagnostics; Research & Academic; Therapeutics Monitoring & Others	Diagnostics	Therapeutics Monitoring & Others
By End User	Hospitals & Clinics; Research Institutions; Diagnostic Laboratories; Pharmaceutical & Biotech Companies	Hospitals & Clinics	Diagnostic Laboratories

Market Segmentation Overview

By Product

Sub-Segment	Key Trend
Instruments	Shift toward ultra-high-field MRI and multi-modal imaging suites
Consumables	Rising demand for specialized electrode arrays and biomarker assay kits
Software & Services	Transition to cloud-hosted analytics and subscription-based platforms

Instruments remain the revenue anchor as hospitals invest in next-generation MRI and electrophysiology hardware. Software & Services is the fastest-growing product category, propelled by the shift from perpetual licenses to recurring subscription models that reduce upfront hospital capital requirements.

By Technology

Sub-Segment	Key Trend
Neuroimaging	Clinical adoption of 7 T MRI and hybrid PET-MR platforms
Molecular & Cellular Assays	Blood-based biomarker panels for Alzheimer's and neuroinflammation
Neurostimulation & Others	Non-invasive TMS expanding into psychiatric and pain indications

Neuroimaging commands the largest technology share, driven by functional and structural brain mapping at resolutions that support early-stage disease detection. Neurostimulation is accelerating as regulatory bodies clear non-invasive devices for a widening range of neurological and psychiatric conditions.

By Application

Sub-Segment	Key Trend
Diagnostics	Early-detection protocols for Alzheimer's, Parkinson's, and stroke
Research & Academic	Government-funded brain-mapping and connectomics initiatives
Therapeutics Monitoring & Others	Closed-loop stimulation and companion diagnostics

Diagnostics leads by application as aging populations and rising disease awareness drive demand for confirmatory imaging and fluid biomarker testing. Therapeutics monitoring is the fastest-growing application, fueled by adaptive neurostimulation systems that adjust therapy parameters based on real-time neural feedback.

By End User

Sub-Segment	Key Trend
Hospitals & Clinics	Centralized neuroimaging suites and integrated stroke pathways
Research Institutions	Multi-site collaborative brain-science programs
Diagnostic Laboratories	Reference-lab consolidation and decentralized biomarker testing
Pharmaceutical & Biotech Companies	CNS pipeline trial imaging and endpoint validation

Hospitals and clinics dominate end-user spending through their concentration of capital-intensive imaging equipment and multidisciplinary neurology teams. Diagnostic laboratories are growing fastest as blood-based neuromarker assays shift testing from hospital settings to high-throughput reference facilities.

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”